Pilot study of Kidney size and renal artery levels in Iraqi people’s sample

2019 ◽  
Author(s):  
Suhail Najjar
Keyword(s):  
2020 ◽  
Vol 48 (6) ◽  
pp. 315-323
Author(s):  
Yixuan Zhang ◽  
Zhitong Ge ◽  
Yahong Wang ◽  
Zhonghui Xu ◽  
Jianchu Li

2009 ◽  
Vol 20 (2) ◽  
pp. 186-191 ◽  
Author(s):  
Elias N. Brountzos ◽  
Kyriaki Tavernaraki ◽  
Athanasios D. Gouliamos ◽  
Dimitrios Degiannis ◽  
Antigoni Chaidaroglou ◽  
...  

2012 ◽  
Vol 55 (2) ◽  
pp. 54 ◽  
Author(s):  
Boo Won Kim ◽  
Min Kyoung Song ◽  
Sochung Chung ◽  
Kyo Sun Kim

2017 ◽  
pp. 109-113
Author(s):  
Ba Lai Luu ◽  
Thanh Thao Nguyen

Objective: To describe the morphologic and hemodynamic changes of renal interlobar artery on ultrasonography, and to evaluate the relationship between RI and kidney size, glomerular filtration rate, and causes of chronic kidney disease. Materials and methods: A cross-sectional study of 50 chronic kidney disease patients from stage 3, and 50 healthy individuals. RI, peak systolic velocity (PSV), end diastolic velocity (EDV) of renal interlobar artery, renal size was measured. Results: The mean RI in chronic kidney disease group and healthy group was 0.68 ± 0.05 and 0.57 ± 0.04 (p <0.05), respectively. RI increases with the stage of chronic kidney disease. There were statistically significant differences in RI of renal lobar arteries between chronic pyelonephritis and chronic glomerulonephritis (p <0.05). There was strong negative correlation and a statistically significant difference between renal lobar renal artery RI with kidney size (horizontal, vertical and thickness) and glomerular filtration level. Conclusion: Renal artery resistance index in patients with chronic kidney disease was higher than in the healthy group. The greater the kidney failure is, the more reduction in size and renal function, and the more increase in renal artery resistance index. Key words: morphologic, hemodynamic, chronic kidney disease, ultrasonography


2010 ◽  
Vol 114 (3) ◽  
pp. c213-c217 ◽  
Author(s):  
Murat Duranay ◽  
Mehmet Kanbay ◽  
Hatice Akay ◽  
Selman Ünverdi ◽  
Hatice Sürer ◽  
...  

1984 ◽  
Vol 25 (5) ◽  
pp. 401-405 ◽  
Author(s):  
L. Ekelund

Percutaneous transluminal renal angioplasty was performed in nine patients (10 kidneys). Immediately following dilatation of the renal artery stenosis, seven of ten kidneys increased in length by at least 0.5 cm (0.5–1.5 cm) indicating improved renal perfusion. This is an observation that does not seem to have been described before. Another, but rare, cause of renal enlargement following angioplasty is hematoma formation which was seen in one of the cases. All of the patients responded well to the treatment and five previously hypertensive patients became normotensive shortly after dilatation.


Author(s):  
Andreas Müller ◽  
Martin Meier

AbstractRenal length and volume are important parameters in the clinical assessment of patients with diabetes mellitus, kidney transplants, or renal artery stenosis. Kidney size is used in primary diagnostics to differentiate between acute (rather swollen kidneys) and chronic (rather small kidney) pathophysiology. Total kidney volume is also an established biomarker in studies for the treatment of autosomal dominant polycystic kidney disease (ADPKD). There are several factors influencing kidney size, and there is still a debate on the value of the measured kidney size in terms of renal function or cardiovascular risk. The renal volume is most often calculated by measuring the three axes of the kidney, on the assumption that the organ resembles an ellipsoid. By default, the longitudinal and transverse diameters of the kidney are measured. In animal models renal length and volume1 are also important parameters in the assessment of organ rejection after transplantation and in determination of kidney failure due to renal artery stenosis, recurrent urinary tract infections, or diabetes mellitus. In general total kidney volume (TKV) is a valuable parameter for predicting prognosis and monitoring disease progression in animal models of human diseases like polycystic kidney disease (PKD) or acute kidney injury (AKI) and chronic kidney disease (CKD).This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This analysis protocol is complemented by two separate chapters describing the basic concept and experimental procedure.


Sign in / Sign up

Export Citation Format

Share Document